<\/b><\/p>\n
<\/b><\/p>\n
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n
Two Cases of SARS-CoV-2 Variant P.1 Identified in Minnesota<\/strong><\/p>\n FRIDAY, March 5, 2021 (HealthDay News) — Two cases of the severe acute respiratory syndrome coronavirus 2 variant P.1 identified in Minnesota are described in a report published in the March 3 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Shortage of Syringes Reported for COVID-19 Shots<\/strong><\/p>\n FRIDAY, March 5, 2021 (HealthDay News) — Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines.<\/p>\n Read Full Text<\/a><\/p>\n Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19<\/strong><\/p>\n FRIDAY, March 5, 2021 (HealthDay News) — A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a study published online March 4 in the Journal of the American Medical Association<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Delayed Local Reactions to mRNA-1273 Vaccination Reported<\/strong><\/p>\n FRIDAY, March 5, 2021 (HealthDay News) — Twelve cases of delayed large local reactions to the mRNA-1273 vaccination against severe acute respiratory syndrome coronavirus 2 are described in a letter to the editor published online March 3 in the New England Journal of Medicine<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Frequency of Urgent Vitreoretinal Surgery Down During Pandemic<\/strong><\/p>\n FRIDAY, March 5, 2021 (HealthDay News) — The frequency of urgent or emergent vitreoretinal surgical procedures decreased during the COVID-19 pandemic, according to a study published online March 4 in JAMA Ophthalmology<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n California Targets Vulnerable Neighborhoods for COVID-19 Vaccination<\/strong><\/p>\n THURSDAY, March 4, 2021 (HealthDay News) — About 40 percent of California’s COVID-19 vaccine doses will be set aside for the most vulnerable neighborhoods in the state, officials said Wednesday.<\/p>\n Read Full Text<\/a><\/p>\n COVID-19 Death Rates 10 Times Higher in Countries Where Most Are Overweight<\/strong><\/p>\n THURSDAY, March 4, 2021 (HealthDay News) — In a finding that suggests overweight people should be prioritized for COVID-19 vaccines, a new report released Thursday shows the risk for death from COVID-19 infection is about 10 times higher in countries where most of the population is overweight.<\/p>\n Read Full Text<\/a><\/p>\n Pediatric Oncology Services Disrupted During Pandemic<\/strong><\/p>\n THURSDAY, March 4, 2021 (HealthDay News) — The COVID-19 pandemic has had a disruptive effect on pediatric oncology services, according to a study published online March 3 in The Lancet Child & Adolescent Health<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Behavioral Health Issues Remain High as Pandemic Continues<\/strong><\/p>\n WEDNESDAY, March 3, 2021 (HealthDay News) — Self-reported symptoms of behavioral health issues remain high as the COVID-19 pandemic continues, according to a research letter published online Feb. 19 in JAMA Network Open<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n NIH Halts Trial of Convalescent Plasma for Mild COVID-19<\/strong><\/p>\n WEDNESDAY, March 3, 2021 (HealthDay News) — A clinical trial evaluating the use of convalescent plasma in patients with mild-to-moderate COVID-19 symptoms has been halted because the treatment did not benefit them, according to the U.S. National Institutes of Health.<\/p>\n Read Full Text<\/a><\/p>\n Dysnatremia Tied to Poorer Prognosis in Hospitalized COVID-19 Patients<\/strong><\/p>\n WEDNESDAY, March 3, 2021 (HealthDay News) — For patients presenting with COVID-19, abnormal sodium levels are associated with mortality and needing ventilatory support, according to a study published online Feb. 24 in the Journal of Clinical Endocrinology & Metabolism<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n Preliminary Data in Israel Show COVID-19 Vaccines Effectively Prevent Severe Disease<\/strong><\/p>\n TUESDAY, March 2, 2021 (HealthDay News) — COVID-19 vaccines seem to have been effective for preventing severe COVID-19 cases in Israel, according to research published in the Feb. 26 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n One-Third of U.S. Adults Continue to Be Hesitant About COVID-19 Vaccines<\/strong><\/p>\n TUESDAY, March 2, 2021 (HealthDay News) — More than one-third of nonelderly U.S. adults report they are unlikely to get a COVID-19 vaccine, according to a report released by the Urban Institute and the Robert Wood Johnson Foundation.<\/p>\n Read Full Text<\/a><\/p>\n Dramatic Decline Seen in COVID-19 Cases, Deaths at U.S. Nursing Homes<\/strong><\/p>\n TUESDAY, March 2, 2021 (HealthDay News) — New COVID-19 cases in U.S. nursing homes have fallen to their lowest number since the Centers for Medicare & Medicaid Services started keeping track in May 2020, which suggests that vaccines are helping and that it might be possible to loosen some nursing home restrictions, a new report says.<\/p>\n Read Full Text<\/a><\/p>\n Response to One Dose of COVID-19 Vaccine Strong for Previously Infected<\/strong><\/p>\n TUESDAY, March 2, 2021 (HealthDay News) — Individuals with previous severe acute respiratory syndrome coronavirus 2 infection generate strong responses to one dose of the BNT162b2 vaccine, according to two research letters published online Feb. 25 in The Lancet<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19<\/strong><\/p>\n TUESDAY, March 2, 2021 (HealthDay News) — Treatment with interleukin-6 receptor antagonists tocilizumab and sarilumab improves outcomes among critically ill patients with COVID-19 receiving organ support in the intensive care unit, according to a study published online Feb. 24 in the New England Journal of Medicine<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its developers.<\/p>\n Read Full Text<\/a><\/p>\n Walmart Expands COVID-19 Vaccination Program<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states.<\/p>\n Read Full Text<\/a><\/p>\n J&J COVID-19 Vaccine Granted Emergency Use Authorization<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration announced Saturday.<\/p>\n Read Full Text<\/a><\/p>\n Axillary Adenopathy Reported After Recent COVID-19 Vaccination<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — In two reports published recently in the American Journal of Roentgenology<\/em>, radiologists address the clinical features of axillary adenopathy seen on breast imaging after COVID-19 vaccination and provide a detailed approach to manage these findings and avoid confusion among patients and clinicians.<\/p>\n Read Full Text<\/a><\/p>\n COVID-19 Outcomes No Worse for People With Asthma<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — COVID-19 outcomes are similar for people with or without asthma, according to a review published online Feb. 8 in the Journal of Asthma<\/em>.<\/p>\n Read Full Text<\/a><\/p>\n High Dose of Vitamin D Does Not Cut COVID-19 Hospital Stay<\/strong><\/p>\n MONDAY, March 1, 2021 (HealthDay News) — A single high dose of vitamin D3 does not shorten length of stay or improve other outcomes among patients hospitalized for COVID-19, according to a study published online Feb. 17 in the Journal of the American Medical Association<\/em>.<\/p>\n